ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders

MARLBOROUGH Mass. Sept. 19 2011 PRNewswire Advanced Cell Technology Inc. "ACT"; OTCBB ACTC a leader in the field of regenerative medicine announced today that it has been issued a patent patent number 8017393 for the Company's proprietary method...